Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MYM Nutraceuticals Inc MYMMF

MYM Nutraceuticals Inc is a Canada based company engaged in the business of acquiring and developing natural remedies. The company is focused on the medical marijuana business by producing cannabis growing facilities and products.

GREY:MYMMF - Post Discussion

MYM Nutraceuticals Inc > sales license
View:
Post by Haiku123 on Apr 09, 2020 3:57pm

sales license

I have received an email from mym regarding sales license

Health Canada first requires new cultivator to grow two crops before issuing a sales license. Our plants are leaving the nursery for the main facility next week. We are able to sell the first two crops to other LP's, however not directly to retail. Revenue will be coming sometime in late q2, early q3
Comment by WeeblesWobble on Apr 10, 2020 12:53pm
Does this mean MYM has sales contract in place with other LP's for first two crops?  Or does MYM still have to find buyers?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities